—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Crinetics Pharmaceuticals Inc（CRNX）— 同类公司组

数据截至2026-10-05 — 评分每个交易日晚间重新计算。分组标准＝首先为共同的Closelook指数成分，其次为行业。Closelook研究日记，不构成投资建议。

Crinetics Pharmaceuticals Inc的Closelook综合评分为49/100，在同类公司组内排名第7位（共7家）——组内评分最高的是BB Biotech AG（73/100）。

名称综合动量质量估值信号距52周高点
CRNX Crinetics Pharmaceuticals Inc4998214ok0.1%
BION.SW BB Biotech AG73619680info13.1%
ONC BeiGene, Ltd.64786632ok6.1%
CAI Caris Life Sciences, Inc. Common Stock61866331ok9.7%
PTGX Protagonist Therapeutics Inc59746211info12.5%
REGN Regeneron Pharmaceuticals Inc59537252bull14.4%
CORT Corcept Therapeutics Incorporated58965024ok3.4%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-05

Quick answers

Crinetics Pharmaceuticals Inc在Closelook覆盖范围内的同类公司有哪些？

分组首先基于共同的Closelook指数成分，其次基于行业：BB Biotech AG (BION.SW)、BeiGene, Ltd. (ONC)、Caris Life Sciences, Inc. Common Stock (CAI)、Protagonist Therapeutics Inc (PTGX)、Regeneron Pharmaceuticals Inc (REGN)、Corcept Therapeutics Incorporated (CORT)。

CRNX相对同类公司的评分如何？

Crinetics Pharmaceuticals Inc的综合评分为49/100，组内排名第7位（共7家），截至2026-10-05；组内最高综合评分为BB Biotech AG（73/100）。Closelook评分为研究日记读数，不构成评级或投资建议。

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.